Publications in collaboration with researchers from Hospital Universitari de Bellvitge (81)

2024

  1. Cardiac resynchronization therapy with triple fusion using the SyncAV dynamic algorithm compared to conventionally optimized biventricular pacing: Results from the multicentric, randomized, double-blinded CRUSTY trial

    Heart Rhythm

  2. Elevated Troponins after COVID-19 Hospitalization and Long-Term COVID-19 Symptoms: Incidence, Prognosis, and Clinical Outcomes—Results from a Multi-Center International Prospective Registry (HOPE-2)

    Journal of Clinical Medicine, Vol. 13, Núm. 9

  3. Invasive Treatment Strategy in Adults With Frailty and Non-ST-Segment Elevation Myocardial Infarction: A Secondary Analysis of a Randomized Clinical Trial

    JAMA network open, Vol. 7, Núm. 3, pp. e240809

  4. Revascularization and outcomes in ischaemic left ventricular dysfunction after heart failure admission: The RevascHeart study

    European Journal of Heart Failure

2023

  1. Effect of Routine Invasive vs Conservative Strategy in Older Adults With Frailty and Non-ST-Segment Elevation Acute Myocardial Infarction: A Randomized Clinical Trial

    JAMA Internal Medicine, Vol. 183, Núm. 5, pp. 407-415

  2. Post-COVID-19 syndrome and diabetes mellitus: a propensity-matched analysis of the International HOPE-II COVID-19 Registry

    Frontiers in Endocrinology, Vol. 14

  3. Spontaneous reperfusion enhances succinate concentration in peripheral blood from stemi patients but its levels does not correlate with myocardial infarct size or area at risk

    Scientific Reports, Vol. 13, Núm. 1

2022

  1. A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction

    Circulation, Vol. 146, Núm. 16, pp. 1196-1206

  2. A comparison of front-line oral anticoagulants for the treatment of non-valvular atrial fibrillation: effectiveness and safety of direct oral anticoagulants in the FANTASIIA registry

    Expert Opinion on Pharmacotherapy, Vol. 23, Núm. 12, pp. 1457-1465

  3. Assessment and Mitigation of Bleeding Risk in Atrial Fibrillation and Venous Thromboembolism: Executive Summary of a European and Asia-Pacific Expert Consensus Paper

    Thrombosis and Haemostasis, Vol. 122, Núm. 10, pp. 1625-1652

  4. Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: A Position Paper from the ESC Working Group on Thrombosis, in collaboration with the European Heart Rhythm Association, the Association for Acute CardioVascular Care and the Asia-Pacific Heart Rhythm Society

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, Vol. 24, Núm. 11, pp. 1844-1871

  5. Corrigendum: Dynamics of Emergency Cardiovascular Hospital Admissions and In-Hospital Mortality During the COVID-19 Pandemic: Time Series Analysis and Impact of Socioeconomic Factors, (Front. Cardiovasc. Med, (2022), 9, (827212), 10.3389/fcvm.2022.827212)

    Frontiers in Cardiovascular Medicine

  6. Current trends on antithrombotic therapy

    REC: CardioClinics

  7. Defective dimerization of FoF1-ATP synthase secondary to glycation favors mitochondrial energy deficiency in cardiomyocytes during aging

    Aging Cell, Vol. 21, Núm. 3

  8. Dynamics of Emergency Cardiovascular Hospital Admissions and In-Hospital Mortality During the COVID-19 Pandemic: Time Series Analysis and Impact of Socioeconomic Factors

    Frontiers in Cardiovascular Medicine, Vol. 9

  9. Impact of Integrated Care Management on Clinical Outcomes in Atrial Fibrillation Patients: A Report From the FANTASIIA Registry

    Frontiers in Cardiovascular Medicine, Vol. 9

  10. Sample size requirement in trials that use the composite endpoint major adverse cardiovascular events (MACE): new insights

    Trials, Vol. 23, Núm. 1

2021

  1. Baseline CHA2DS2-VASc score and prognosis in octogenarians with non-ST segment elevation acute coronary syndrome

    International Journal of Clinical Practice, Vol. 75, Núm. 6

  2. Citric acid cycle metabolites predict infarct size in pigs submitted to transient coronary artery occlusion and treated with succinate dehydrogenase inhibitors or remote ischemic perconditioning

    International Journal of Molecular Sciences, Vol. 22, Núm. 8

  3. Comorbidity burden and revascularization benefit in elderly patients with acute coronary syndrome

    Revista Espanola de Cardiologia, Vol. 74, Núm. 9, pp. 765-772